Antibodies are a major part of growing biologics drug market. An antibody binds with particular antigen with similar binding regions and performs therapeutic action. Antibody therapeutics are most common in oncological, immunological and infectious disorders. Antibody analysis is important to determine the specificity and potential side effects involved in the pathology of the disease. Antibody analysis in life science research is done to study the causes of disease and its biological process with thorough investigation and experimentation. Antibody analysis is done during the development and manufacturing process in biopharmaceuticals to monitor the safety and stability of the final drug product. According to the Journal of Biomedical Science, till December 2019 the U.S. Food and Drug Administration (USFDA) approved 79 therapeutic monoclonal antibodies.
Leading biopharmaceutical companies are focused on the development of coronavirus cure amid pandemic delaying research and development process of other drug candidates in antibody analysis market. Covid-19 has led to lockdown in several countries disrupting supply chain activities of antibody analysis market. Reduction in diagnosis and treatment adoption rate tend to slower antibody analysis market growth.
Antibody Analysis Market: Drivers and Restraints
Increasing prevalence of various types of chronic disorders are expected to drive the growth of antibody analysis market. Government investment from an organization such as the National Institutes of Health (NIH), towards drug development is propelling antibody analysis market growth. Increasing collaborative research and development activities among leading biopharmaceutical innovative players is expected to fuel the growth antibody analysis market. For instance, in July 2020 Takeda Pharmaceutical Company Limited and Twist Bioscience, announced a collaboration to discover, validate and optimize new antibody drug candidates in therapeutic areas of oncology, neuroscience, gastroenterology and rare diseases. Advancement of technology boosts demand for antibody analysis market. Higher set up cost associated with antibody analysis hinders the market growth. Stringent regulatory requirements for drug development challenges antibody analysis market growth.
Antibody Analysis Market: Segmentation
Based on the antibody type, the global antibody analysis market can be segmented as:
Based on the technique, the global antibody analysis market is segmented as:
Based on indication, the global antibody analysis market is segmented as:
Based on the end-users, the global antibody analysis market is segmented as:
Antibody Analysis Market: Overview
Monoclonal antibodies segment is expected to hold a major revenue share of antibody analysis market during the forecast period. Western blotting is the most common technique with increasing proteomics and genomics research in antibody analysis market. Oncology and infectious disorders are creating significant demand with a high prevalence rate for antibody analysis market. Whereas, biopharmaceutical companies segment is the largest end-user for antibody analysis market with increasing research and development activities.
Antibody Analysis Market: Region-wise Outlook
North America will continue to dominate the antibody analysis market in the coming decade with a high rate of approvals and commercialization of pharmaceutical drugs. The high rate of prevalence of chronic disorders increases the demand for antibody analysis market in North America. Europe is the second leading region in the antibody analysis market with increased investments towards research and development activities. Asia-pacific is lucrative with a higher growth rate in the antibody analysis market during the forecast period with a large patient population in the region and improving healthcare infrastructure. The Middle East and Africa are expected to observe the least growth in antibody analysis market due to less healthcare expenditure in the region.
Antibody Analysis Market: Key Market Participants
Major players in antibody analysis market are Abcam Plc., Thermo Fisher Scientific, Inc., Agilent Technologies, F. Hoffmann-La Roche Ltd., Eli Lily and Company, Johnson & Johnson, Becton Dickinson and Company, Merck & Co., Bio-Rad Laboratories Inc., Cell Signalling Technology, Inc., PerkinElmer, Inc., Teva Pharmaceuticals Industries Limited, Danaher Corporation, and others.
The research report on antibody analysis market presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report on antibody analysis market provides analysis and information according to market segments such as antibody type, technique, indication, end-user and region.
The report covers exhaust analysis on:
Regional analysis includes:
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.